[Update on intravenous lysis treatment : The REVISION trial].

Background null To date, no evidence-based treatment for acute non-arteritic central retinal artery occlusion (CRAO) exists. Considering the limited ischemia tolerance of the null and the results of multiple case series, increasing expectations are directed towards an early intravenous thrombolysis within 4.5 h after CRAO onset. null Objective null The current literature regards timely retinal reperfusion as the only potentially beneficial...